Watch Now Agenda *Agenda subject to change 6:30 PM Guest Arrival and Cocktail Reception 7:00 PM Welcome Participants Tyler Watson Executive Vice President of Marketing, The Atlantic Susan Sweeney Executive Vice President of Obesity and Related Conditions, Amgen 7:05 PM The Defining Scale Shift in Obesity Therapeutics Summary The first wave of obesity medications proved that biology works and sparked extraordinary demand
You can alleviate your symptoms by making a few lifestyle changes
However, the longer-term impact of GLP-1RAs is likely to be positive for the industry, driven by an expected higher uptake of physical activity by previously overweight individuals, and the growing evidence of the importance of exercise to preserving muscle mass
GLP-1 medications don't restructure your eating habits, meal timing, or food choices
Is semaglutide safe in patients with thyroid cancer history
There are many different types of glutathione cream available on the market